Skip to content
AdminApr 10, 2019< 1 min read

FDA, Brigham and Women’s to test if RWE is ripe now for replacing clinical drug trials

The FDA, in collaboration with Brigham and Women's Hospital and Aetion, is conducting a pilot project to assess whether real-world evidence (RWE) can accurately predict the outcomes of ongoing randomized clinical trials, potentially revolutionizing the drug approval process by substituting lengthy and expensive trials with existing patient data, with interim results expected by mid-2020 and full results by the end of the year.

Read More

Admin

RELATED ARTICLES

AdminApr 10, 2019< 1 min read

Aetion, Brigham and Women's Partnerships will inform FDA RWE standards

The FDA is partnering with Brigham and Women's Hospital and Aetion to expand its use of real-world evidence (RWE) in ...
Start Reading
AdminApr 10, 20193 min read

FDA expands real-world evidence partnership with Brigham and Women's Hospital and Aetion

NEW YORK, April 10, 2019 /PRNewswire/ -- Aetion today announced the U.S. Food & Drug Administration (FDA) and Brigham and ...
Start Reading
AdminApr 12, 2019< 1 min read

Using real-world data, the FDA aims to predict randomized trial results before they’re done

The US Food and Drug Administration (FDA) is expanding its real-world evidence (RWE) program with Aetion and Brigham and ...
Start Reading